Robert E. Hoffman - 15 May 2025 Form 4 Insider Report for CytoDyn Inc. (CYDY)

Role
Chief Financial Officer
Signature
/s/ Tyler Blok, attorney-in-fact for Robert E. Hoffman
Issuer symbol
CYDY
Transactions as of
15 May 2025
Net transactions value
$0
Form type
4
Filing time
22 May 2025, 20:31:53 UTC
Previous filing
02 Apr 2025
Next filing
02 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Hoffman Robert E. Chief Financial Officer 1111 MAIN STREET, SUITE 660, VANCOUVER /s/ Tyler Blok, attorney-in-fact for Robert E. Hoffman 22 May 2025 0001166288

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYDY Non-qualified stock option (right to buy) Award $0 +1,000,000 $0.000000 1,000,000 15 May 2025 Common Stock 1,000,000 $0.4100 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This grant was approved by the Company's Compensation Committee effective May 15, 2025, pursuant to the Issuer's 2012 Equity Incentive Plan, as amended (the "Plan").
F2 250,000 shares will vest on May 15, 2026, and the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Plan ) from May 2026 through April 2029.